Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

Today, 12:15 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)

ADMA

1 minute read

Entera Bio Q2 EPS $(0.20) Misses $(0.12) Estimate, Sales $109.00K Beat $90.00K Estimate

By Luke J Jacobi

Today, 12:15 PM

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.12) by 66.67 percent. This is a 17.65 percent decrease over losses of $(0.17) per share from the

ENTX

8 minute read

Earnings Scheduled For August 16, 2021

By Benzinga Insights

Today, 12:15 PM

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

4 minute read

Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021

By Shanthi Rexaline

Today, 12:15 PM

Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date compared to the roughly 14% gain for the S&P 500 Index.

ANVS

1 minute read

Entera Bio Shares Spike Higher Following Co. Press Release Highlighting Upcoming Jun. 30 Conference Call To Discuss ‘Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis’

By Benzinga Newsdesk

Today, 12:15 PM

Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced it will conduct a conference call to discuss results from its successfully completed Phase 2

ENTX

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Thursday, Jun. 24, 2021: DKNG, ROKU, UPS, DOCS, ENTX

By Benzinga Newsdesk

Today, 12:15 PM

Today's 5 Stock Ideas DraftKings (DKNG) - Shares will likely see added attention Thursday following positive guidance from peer in the gambling space, Penn National Gaming (PENN). Roku

CMCSA

5 minute read

The Daily Biotech Pulse: Lilly Spikes On Alzheimer’s Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO

By Shanthi Rexaline

Today, 12:15 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23)

ABCL

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:15 PM

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.

ACST

2 minute read

Where Might Entera Bio Stock End Up After Rallying Wednesday

By Tyler Bundy

Today, 12:15 PM

Entera Bio Ltd (NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final six-month bone mineral density results from the completed Phase 2 clinical trial of EB613 for osteoporosis.

ENTX

3 minute read

Mid-Afternoon Market Update: Patterson Companies Drops On Earnings Miss; Entera Bio Shares Gain

By Lisa Levin

Today, 12:15 PM

Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,918.98 while the NASDAQ rose 0.16% to 14,276.41. The S&P also rose, gaining 0.05% to 4,248.47.

BLPH